Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism
Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism
批准号:
10725231
负责人:
Hadiza S Kazaure
金额:
$32.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2025-08-14
关键词:
AffectAgeAgingAlgorithmsAlzheimer&aposs DiseaseAmbulatory Care FacilitiesAmericanArtificial IntelligenceAwardBiochemicalBiochemical MarkersBiologicalCalciumCardiovascular systemCaringCharacteristicsChronicClinicClinic VisitsClinicalClinical assessmentsCognitionCognitive deficitsCreatinineDataDiagnosisDisease of parathyroid glandsDocumentationEarly DiagnosisEarly treatmentElderlyElectronic Health RecordEndocrineEndocrine Surgical ProceduresEndocrine System DiseasesEndocrinologyExclusionFractureGoalsGrowthHealthHealth systemHypercalcemiaHyperparathyroidismImpaired cognitionImpairmentKidneyKidney CalculiKnowledgeLearningMachine LearningMeasuresMemoryMemory impairmentMorbidity - disease rateNatural Language ProcessingNeurocognitionNeurocognitiveNeurocognitive DeficitNeuropsychological TestsOperative Surgical ProceduresOsteoporosisOutpatientsPTH geneParathyroid glandParathyroidectomyPatientsPatternPolypharmacyPopulationPrevalencePrizeProceduresProcessQuality of lifeRenal functionResearchResearch MethodologyResearch PersonnelSpecialistSurveysSymptomsTechniquesTestingTimeTwin Multiple BirthUnited StatesUnited States National Institutes of HealthUniversitiesVerbal LearningVisitVisuospatialVulnerable PopulationsWorkaging populationblindbone lossbrain fogcareer developmentcognitive functioncognitive testingcomorbiditydemographicsfollow-upfunctional declinehigh riskhuman old age (65+)improvedmachine learning methodneurocognitive testnon-verbalnovel strategiesolder patientpreservationprospectivepublic health relevanceresponsesymptomatic improvementtreatment guidelinestreatment response
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Primary hyperparathyroidism (PHPT) is a common endocrine disorder affecting ~1 million older (age ≥ 65 years)
Americans. Untreated PHPT is associated with osteoporosis, fractures, kidney stones, renal function decline,
and cardiovascular-related morbidity. However, more than 80% of patients with PHPT lack classic symptoms
such as kidney stones; they are often “asymptomatic” even as bone loss and renal decline silently occur.
Neurocognitive (NC) symptoms, including memory impairment and cognitive dysfunction (“brain fog”), are
common subjective complaints and may be the only symptoms with which patients present. Studies utilizing
objective neurocognitive testing have found that PHPT patients have significantly diminished concentration
levels, impairments in nonverbal learning processes, and compromised constructional and visuospatial memory.
These impairments result in significant functional decline and decreased quality of life (QoL) in older adults – the
very subpopulation that prizes the preservation of cognition as a critical health metric.
Parathyroidectomy, commonly done as an outpatient procedure, is the first-line treatment for PHPT and is often
curative. Several studies have demonstrated improvements (and even normalization) in cognitive function and
quality of life following surgery. Nonetheless, PHPT is too often overlooked as a diagnosis, and up to 70% of
older adults are undertreated for PHPT even when they meet the criteria for surgical treatment. Further, no
studies on NC symptoms in older adults with PHPT have been conducted to date. Thus, there is a paucity of
data on PHPT-associated NC symptoms among older adults, including specific cognitive deficits that may be
prevalent among them and their response to treatment.
In this proposal, we aim to (a) prospectively characterize NC symptoms and treatment-response patterns for
older adults with PHPT using a validated subjective survey instrument and a battery of 3 objective NC measures
and (b) develop an artificial intelligence-based strategy incorporating machine learning and natural language
processing techniques, to expedite PHPT diagnosis. All studies will be conducted within the Duke University
Health System.
The aims of the proposal are:
1: Characterize NC symptoms of older adults with PHPT
2: Delineate factors associated with treatment-response patterns among older patients with PHPT-associated
NC symptoms
3: Develop an artificial intelligence-based algorithm to expedite the diagnosis of PHPT among older adults with
or without NC symptoms
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: